{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:16:35Z","timestamp":1767705395392,"version":"3.44.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1053\/j.semnuclmed.2020.06.002","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T08:19:01Z","timestamp":1594282741000},"page":"471-483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Interaction of Genomics, Molecular Imaging, and Therapy in Gastrointestinal Tumors"],"prefix":"10.1053","volume":"50","author":[{"given":"Richard L.","family":"Wahl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.semnuclmed.2020.06.002_bib0001","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1146\/annurev-pathol-011110-130235","article-title":"Molecular genetics of colorectal cancer","volume":"6","author":"Fearon","year":"2011","journal-title":"Annu Rev Pathol: Mech Dis"},{"key":"10.1053\/j.semnuclmed.2020.06.002_bib0002","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature11252","article-title":"Comprehensive molecular characterization of human colon and rectal cancer","volume":"487","year":"2012","journal-title":"Nature"},{"key":"10.1053\/j.semnuclmed.2020.06.002_bib0003","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.cell.2017.05.046","article-title":"Comprehensive and integrative genomic characterization of hepatocellular carcinoma","volume":"169","author":"Wheeler","year":"2017","journal-title":"Cell"},{"key":"10.1053\/j.semnuclmed.2020.06.002_bib0004","unstructured":"Frucht H, Lucas AL: Molecular genetics of colorectal cancer, In DMF Savarese (Ed.), UpToDate. Available at: https:\/\/www.uptodate.com\/contents\/molecular-Hrubangenetics-of-colorectal-cancer. Accessed May 23, 2020."},{"key":"10.1053\/j.semnuclmed.2020.06.002_bib0005","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1311194","article-title":"Multitarget stool DNA testing for colorectal-cancer screening","volume":"370","author":"Imperiale","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2020.06.002_bib0006","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1158\/1541-7786.MCR-17-0060","article-title":"Comprehensive genomic profiling of metastatic squamous cell carcinoma of the anal canal","volume":"15","author":"Morris","year":"2017","journal-title":"Mol Cancer Res"},{"key":"10.1053\/j.semnuclmed.2020.06.002_bib0007","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1126\/science.1164368","article-title":"Core signaling pathways in human pancreatic cancers revealed by global genomic analyses","volume":"321","author":"Jones","year":"2008","journal-title":"Science"},{"key":"10.1053\/j.semnuclmed.2020.06.002_bib0008","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ccell.2017.07.007","article-title":"Integrated genomic characterization of pancreatic ductal adenocarcinoma","volume":"32","author":"Raphael","year":"2017","journal-title":"Cancer cell"},{"key":"10.1053\/j.semnuclmed.2020.06.002_bib0009","unstructured":"Hruban RH. Molecular pathogenesis of exocrine pancreatic cancer. In DMF Savarese (Ed.), UpToDate. Available at:https:\/\/www.uptodate.com\/contents\/molecular-pathogenesis-of-exocrine-pancreatic-cancer. Accessed May 23, 2020."},{"key":"10.1053\/j.semnuclmed.2020.06.002_bib0010","unstructured":"Morgan J, Raut C, Duesing A, et al: Epidemiology, classification, clinical presentation, prognostic features, and diagnostic work-up of gastrointestinal stromal tumors (GIST) In S. Shah (Ed.), UpToDate. Available at:https:\/\/www.uptodate.com\/contents\/epidemiology-classification-clinical-presentation-prognostic-features-and-diagnostic-work-up-of-gastrointestinal-stromal-tumors-gist. Accessed May 23, 2020."},{"key":"10.1053\/j.semnuclmed.2020.06.002_bib0011","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1016\/j.celrep.2017.02.033","article-title":"Integrative genomic analysis of cholangiocarcinoma identifies distinct IDH-mutant molecular profiles","volume":"18","author":"Farshidfar","year":"2017","journal-title":"Cell Rep"},{"key":"10.1053\/j.semnuclmed.2020.06.002_bib0012","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature21063","article-title":"Whole-genome landscape of pancreatic neuroendocrine tumours","volume":"543","author":"Scarpa","year":"2017","journal-title":"Nature"},{"key":"10.1053\/j.semnuclmed.2020.06.002_bib0013","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s41181-019-0069-0","article-title":"Targeting of activated fibroblasts for imaging and therapy","volume":"4","author":"Lindner","year":"2019","journal-title":"EJNMMI Radiopharm Chem"},{"key":"10.1053\/j.semnuclmed.2020.06.002_bib0014","doi-asserted-by":"crossref","first-page":"6094","DOI":"10.1158\/1078-0432.CCR-17-0899","article-title":"Real-time genomic profiling of pancreatic ductal adenocarcinoma: potential actionability and correlation with clinical phenotype","volume":"23","author":"Lowery","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semnuclmed.2020.06.002_bib0015","first-page":"1732","article-title":"The value of [11 C]-acetate PET and [18 F]-FDG PET in hepatocellular carcinoma before and after treatment with transarterial chemoembolization and bevacizumab","volume":"44","author":"Li","year":"2017","journal-title":"EJNMMI"},{"key":"10.1053\/j.semnuclmed.2020.06.002_bib0016","first-page":"185","article-title":"68Ga-labeled prostate-specific membrane antigen is a novel PET\/CT tracer for imaging of hepatocellular carcinoma: A prospective pilot study","volume":"60","author":"Kesler","year":"2019","journal-title":"JNM"},{"key":"10.1053\/j.semnuclmed.2020.06.002_bib0017","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/SLA.0000000000003022","article-title":"Genetic analysis of small well-differentiated pancreatic neuroendocrine tumors identifies subgroups with differing risks of liver metastases","volume":"271","author":"Pea","year":"2020","journal-title":"Ann Surg"},{"key":"10.1053\/j.semnuclmed.2020.06.002_bib0018","first-page":"1421","article-title":"Prediction of response to immune checkpoint inhibitor therapy using early-time-point 18F-FDG PET\/CT imaging in patients with advanced melanoma","volume":"58","author":"Cho","year":"2017","journal-title":"JNM"},{"key":"10.1053\/j.semnuclmed.2020.06.002_bib0019","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1038\/s41591-018-0255-8","article-title":"89 Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer","volume":"24","author":"Bensch","year":"2018","journal-title":"Nat Med"},{"key":"10.1053\/j.semnuclmed.2020.06.002_bib0020","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1158\/0008-5472.CAN-15-1707","article-title":"An effective immuno-PET imaging method to monitor CD8-dependent responses to immunotherapy","volume":"76","author":"Tavar\u00e9","year":"2016","journal-title":"Cancer Res"},{"key":"10.1053\/j.semnuclmed.2020.06.002_bib0021","doi-asserted-by":"crossref","first-page":"6050","DOI":"10.1200\/JCO.2018.36.15_suppl.6050","article-title":"A study to evaluate immunological response to PD-1 inhibition in squamous cell carcinoma of the head and neck (SCCHN) using novel PET imaging with [18F] F-AraG","volume":"36","author":"Colevas","year":"2018","journal-title":"JCO"},{"key":"10.1053\/j.semnuclmed.2020.06.002_bib0022","doi-asserted-by":"crossref","first-page":"eaan2415","DOI":"10.1126\/scitranslmed.aan2415","article-title":"Direct detection of early-stage cancers using circulating tumor DNA","volume":"9","author":"Phallen","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1053\/j.semnuclmed.2020.06.002_bib0023","doi-asserted-by":"crossref","first-page":"10202","DOI":"10.1073\/pnas.1704961114","article-title":"Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers","volume":"114","author":"Cohen","year":"2017","journal-title":"Proc Natl Acad Sci"},{"key":"10.1053\/j.semnuclmed.2020.06.002_bib0024","doi-asserted-by":"crossref","first-page":"eabb9601","DOI":"10.1126\/science.abb9601","article-title":"Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention","author":"Lennon","year":"2020","journal-title":"Science"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299820300684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299820300684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T22:36:20Z","timestamp":1757543780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299820300684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0001299820300684"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2020.06.002","relation":{},"ISSN":["0001-2998"],"issn-type":[{"type":"print","value":"0001-2998"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Interaction of Genomics, Molecular Imaging, and Therapy in Gastrointestinal Tumors","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nuclear Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2020.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}